GlassScriptPhysician profile
Eva Jakabovics
NPI 1861495988
$3,160.82
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $525 · 2021: $723 · 2022: $545 · 2023: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $705.82 | 2019-2023 | Fasenra, Tezspire |
| Kaleo, INC. | $328.99 | 2019-2023 | Auvi-Q |
| Regeneron Healthcare Solutions, INC. | $323.32 | 2019-2022 | |
| Csl Behring | $307.78 | 2019-2023 | Hizentra, Haegarda |
| Glaxosmithkline, LLC. | $227.25 | 2019-2023 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $212.32 | 2020-2022 | |
| Octapharma USA, INC. | $158.21 | 2019-2023 | Cutaquig |
| Pfizer INC. | $156.30 | 2019-2021 | |
| Amgen INC. | $149.14 | 2021-2023 | Tezspire |
| Genentech USA, INC. | $146.64 | 2019-2023 | Xolair |
| Bio Products Laboratory USA, INC. | $101.96 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $83.89 | 2020-2021 | |
| Shire North American Group INC | $80.38 | 2019 | |
| Grifols USA, LLC | $55.65 | 2020-2021 | |
| Genzyme Corporation | $34.88 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.56 | 2019 | |
| Leo Pharma INC. | $20.74 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.13 | 2021 | |
| Biocryst US Sales Co., LLC | $14.92 | 2022 | |
| Horizon Therapeutics Plc | $13.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Jakabovics listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.